Encouraging Diversity and Inclusion in Science Via the Book Opening Doors: <italic toggle="yes">Joan Steitz and Jennifer Doudna of the RNA World</italic> by Amy Cheng Vollmer

Get full text

Prospects of genome editing using CRISPR/CAS or how to master genetic scissors. Nobel Prize in Chemistry 2020 by S. V. Komisarenko, S. I. Romaniuk

Subjects: Get full text

CRISPR System: From Adaptive Immunity to Genome Editing by Jennifer Doudna

Get full text

RNA-programmed genome editing in human cells by Martin Jinek, Alexandra East, Aaron Cheng, Steven Lin, Enbo Ma, Jennifer Doudna

Get full text

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells by Judd F. Hultquist, Kathrin Schumann, Jonathan M. Woo, Lara Manganaro, Michael J. McGregor, Jennifer Doudna, Viviana Simon, Nevan J. Krogan, Alexander Marson

Get full text

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2 by Annoj Thavalingam, Zhi Cheng, Bianca Garcia, Xue Huang, Megha Shah, Wei Sun, Min Wang, Lucas Harrington, Sungwon Hwang, Yurima Hidalgo-Reyes, Erik J. Sontheimer, Jennifer Doudna, Alan R. Davidson, Trevor F. Moraes, Yanli Wang, Karen L. Maxwell

Get full text

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination by Rahul K. Suryawanshi, Taha Y. Taha, Maria McCavitt-Malvido, Ines Silva, Mir M. Khalid, Abdullah M. Syed, Irene P. Chen, Prachi Saldhi, Bharath Sreekumar, Mauricio Montano, Kafaya Foresythe, Takako Tabata, G. Renuka Kumar, Alicia Sotomayor-Gonzalez, Venice Servellita, Amelia Gliwa, Jenny Nguyen, Noah Kojima, Teresa Arellanor, Aallyah Bussanich, Victoria Hess, Maria Shacreaw, Lauren Lopez, Matthew Brobeck, Fred Turner, Yuzhu Wang, Sydney Ghazarian, Gregg Davis, Diviana Rodriguez, Jennifer Doudna, Lee Spraggon, Charles Y. Chiu, Melanie Ott

Get full text

CRISPR/Cas9 from bench to bedside: what clinicians need to know before application? by Zi-Qing Li, Chao-Hong Li

“…Emmanuelle Charpentier and Dr. Jennifer Doudna won the Nobel Prize in Chemistry for their pioneering work in precise genome editing using the CRISPR technology. …”
Get full text

Understanding on CRISPR/Cas9 mediated cutting-edge approaches for cancer therapeutics by Rudrarup Bhattacharjee, Lopamudra Das Roy, Amarendranath Choudhury

“…(J Bacteriol 169:5429–5433, 1987) and the journey comprises the recent Nobel Prize award (2020), conferred to Emmanuelle Charpentier and Jennifer Doudna. Cumulatively, the CRISPR has a short, compact, and most discussed success of its application in becoming one of the most versatile and paradigm shifting technologies of Biological Research. …”
Get full text

Addressing Conflicts of Interest and Conflicts of Commitment in Public Advocacy and Policy Making on CRISPR/Cas-Based Human Genome Editing by Alexander Christian

“…Leading experts on CRISPR/Cas-based genome editing—such as 2020 Nobel laureates Jennifer Doudna and Emmanuelle Charpentier—are not only renowned specialists in their fields, but also public advocates for upcoming regulatory frameworks on CRISPR/Cas. …”
Get full text

A review on CRISPR-Cas9 and its role in cancer immunotherapy by Rashi A. Bhavsar, Vishwa Maharajan, Evan Joseph, Salai S. Sumukhi, Akshatha Banadka, Kokila Srinivasa

“…The Nobel Prize in Chemistry was awarded to Emanuelle Charpentier and Jennifer Doudna for their work on CRISPR-Cas9 and its application as a genome engineering tool. …”
Get full text

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer by Huimin Zhang, Chunhong Qin, Changming An, Xiwang Zheng, Shuxin Wen, Wenjie Chen, Xianfang Liu, Zhenghua Lv, Pingchang Yang, Wei Xu, Wei Gao, Yongyan Wu

“…Abstract The 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna for the development of the Clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease9 (CRISPR/Cas9) gene editing technology that provided new tools for precise gene editing. …”
Get full text

Shifting Perceptions of CRISPR by Camille Castelyn

“…Photo by National Cancer Institute on Unsplash INTRODUCTION More than 20 cell and gene therapies are now available to safely minimize genetic diseases such as retinal dystrophy (LUXTURNA), some B-cell lymphomas (YESCARTA), and B-cell lymphoblastic leukemia (KYMRIAH).[1] One such gene-editing tool is Clustered Regular Inter Spaced Palindromic Repeats (CRISPR) and its associated proteins or CRISPR-Cas. Jennifer Doudna and Emmanuelle Charpentier described CRISPR’s potential as an accurate genome editing tool in 2012. …”
Get full text

The Dubious Benefits of Germline Editing by Jennifer Gumer

“…In 2012, Berkeley scientist Jennifer Doudna and team demonstrated that CRISPR could be reprogrammed to target and alter ostensibly any gene of any organism on earth [3].  …”
Get full text